Rosuvastatin is suitable for primary hyperlipidemia (IIa, including heterozygous familial hypercholesterolemia) or mixed dyslipidemia (IIb) that cannot be properly controlled by diet and non-pharmacological interventions (such as exercise therapy and weight reduction). Rosuvastatin is also indicated in patients with homozygous familial hypercholesterolemia, as an adjuvant to dietary control and other lipid-lowering measures (such as LDL removal therapy), or when these methods are not applicable.